Abstract #3922

Applying 2HG MRS in glioma patients during routine clinical MRI examination

Zahra Shams¹, Sarah M. Jacobs¹, Jan W. Dankbaar¹, Changho Choi², Dennis W.J. Klomp¹, Jannie P. Wijnen¹, and Evita C. Wiegers¹

¹Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands, ²Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX, United States

2HG is a valuable biomarker to detect mutational status of glioma patients. Therefore, it is of great value to be widely integrated into clinical practice. This study investigates the performance of along echo time (PRESS 97ms) ¹H MRS protocol at 3Tesla to be used in routine clinical glioma imaging.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.